Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 5 1
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 9 0
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 6 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/23/2021 7 0
Excel (.xslx) CSV (.csv)